
|Articles|November 3, 2021
THREAD Acquires Modus Outcomes
Advertisement
THREAD has acquired Modus Outcomes. Headquartered in Cambridge, Mass., Modus Outcomes is a research consultancy that supports the design and selection of electronic clinical outcome assessments (eCOA), participant-focused trial design and scientific delivery of DCTs.
With this acquisition, THREAD will bring together its eCOA technology platform with Modus' services. Modus brings to THREAD:
- Knowledge in qualitative research, advanced psychometric analysis and biostatistics
- Consulting capabilities specializing in patient-centered outcomes strategies, including instrument design/selection and regulatory support
- Outcomes researchers and company partners, Dr. Patrick Marquis, CEO, Dr. Stefan Cano, chief scientific officer, and Dr. Antoine Regnault, global lead, Statistics
- A team of 40 holding an array of certifications and specializations
- Offices in London and Lyon, France
Financial details of the acquisition are not being disclosed.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Tufts CSDD Analysis Finds AI Clinical Monitoring Agent Can Generate Up to $21 Million in Net Financial Value Per Drug Development Program
2
Beyond Compliance: ProofPilot's Joseph Kim and Lauren Briggs on Making Clinical Trial Training Actually Work
3
ACT Brief: Efficacy Ceiling Breakthrough in Autoimmune Disease, Early-Career Retention and Burnout Prevention, and PRV Program Catalyzing Rare Disease Investment
4
Breaking the Efficacy Ceiling in IBD and Beyond
5



